Cafepharma Today

May 15 2025 - FDA approves Amneal's self-administered migraine treatment
FDA approves Amneal's self-administered migraine treatment
VC firm reveals plan for 30K-square-foot biotech incubator space in New Jersey
Philips taps Nvidia to build AI model for MRI
FDA delays decision on Biohaven's rare disease drug filing, plans adcomm
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Is 2012 Make or Break for Cell Therapeutics?
Motley Fool
Thursday, December 29, 2011 - 10:28pm
tags:
Cell Therapeutics, pixantrone
Why Profitable Pfizer Won't Fall Off The Patent Cliff Anytime Soon
Seeking Alpha
Thursday, December 29, 2011 - 10:17pm
tags:
Pfizer, patents, patent cliff
Biotech Stocks At A Critical Juncture
Investopedia.com
Thursday, December 29, 2011 - 1:32pm
tags:
Jazz Pharmaceuticals, Oncothyreon, Questcor, Indenix
Pfizer's offer of discount Lipitor prompts outcry
Winston-Salem Journal, NC
Thursday, December 29, 2011 - 12:43pm
tags:
Lipitor, Pfizer, drug discounts
Five Predictions For Biotech And Medicine In 2012
Forbes
Thursday, December 29, 2011 - 12:35pm
tags:
biotech, India, devices, genetics, PBMs
Ring in Generics in 2012 and Beyond
Zacks.com
Thursday, December 29, 2011 - 12:13pm
tags:
generics, Dr Reddy's, Sanofi, Forest Labs, Watson, Pfizer, Eli Lilly, Novartis, JNJ, Teva Pharmaceuticals, Abbott Laboratories, Mylan, Merck
Onyx put selling hinges on time decay
Yahoo/optionMONSTER
Thursday, December 29, 2011 - 12:01pm
tags:
ONYX Pharmaceuticals, regorafenib
Abbott Labs: Dividend Dynamo or the Next Blowup?
Motley Fool
Thursday, December 29, 2011 - 11:53am
tags:
Abbott Laboratories, dividends
Teva Pharmaceutical Releases Generic Version of HIV Drug in U.S.
Bloomberg
Thursday, December 29, 2011 - 11:53am
tags:
Teva Pharmaceuticals, generics, HIV, GSK, Combivir
Johnson & Johnson seeks FDA approval for third use for its new anticlotting drug, Xarelto
Yahoo/AP
Thursday, December 29, 2011 - 11:52am
tags:
JNJ, FDA, anti-clotting, Xarelto
5-Star Stocks Poised to Pop: Novartis
Motley Fool
Thursday, December 29, 2011 - 11:51am
tags:
Novartis
Illumina Accuses Life Technologies of Infringing Patent
Bloomberg
Thursday, December 29, 2011 - 10:06am
tags:
Illumina, Life Technologies, patents
Marshall Edwards Adds $2 Million in Private Placement
Yahoo
Thursday, December 29, 2011 - 10:05am
tags:
Marshall Edwards, financing
2 Healthcare Stocks That Should Rebound In 2012 After A Poor 2011
Seeking Alpha
Thursday, December 29, 2011 - 10:04am
tags:
Warner Chilcott, Life Technologies
Mead Johnson confirms FDA visits in Enfamil probe
Reuters
Thursday, December 29, 2011 - 10:03am
tags:
FDA, Enfamil, Mead Johnson, infant formula
Biotech Post-Holiday Regifting
Motley Fool
Wednesday, December 28, 2011 - 6:18pm
tags:
Emergent BioSolutions, Abbott Laboratories, Teva Pharmaceuticals, Immunomedics, UCB Pharmaceuticals, Exelixis, JNJ, Eli Lilly, Vertex Pharmaceuticals
Alexion Pharma to buy Enobia for up to $1.08B
Yahoo/AP
Wednesday, December 28, 2011 - 6:16pm
tags:
Alexion, Enobia, M&A
Fate on Gilead Quad Set for Aug '12
Yahoo/Zacks
Wednesday, December 28, 2011 - 6:15pm
tags:
Quad, Gilead, HIV, FDA
Year in Review: Melanoma Drug Still on a Roll
Med Page Today
Wednesday, December 28, 2011 - 3:16pm
tags:
melanoma, Zelboraf, Roche
Pharma winners of 2011 could keep surging next year
Investorplace
Wednesday, December 28, 2011 - 12:08pm
tags:
Amgen, Biogen Idec, Celgene, Gilead, Pharmasset, Alexion, Regeneron

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.